0.53 CNY
8.26 M CNY
163.45 M CNY
About SHANGHAI RENDU BIOTECHNOLOGY
Sector
Industry
CEO
Ming Hui Yu
Website
Headquarters
Shanghai
Founded
2007
ISIN
CNE1000059K5
FIGI
BBG011J505C9
Shanghai Rendu Biotechnology Co., Ltd. develops molecular diagnostic tests. It mainly focuses on RNA molecular diagnostic technology and products. It engages in research & development, production and sales of molecular diagnostic reagents and equipment integrated products. The company is committed to the development and promotion of RNA based on real-time fluorescent constant temperature amplification detection technology (SAT technology for short) molecular diagnostic products. Shanghai Rendu Biotechnology was founded on June 13, 2007 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 688193 is 41.48 CNY — it has decreased by −0.98% in the past 24 hours. Watch SHANGHAI RENDU BIOTECHNOLOGY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI RENDU BIOTECHNOLOGY stocks are traded under the ticker 688193.
688193 stock has fallen by −0.22% compared to the previous week, the month change is a −9.83% fall, over the last year SHANGHAI RENDU BIOTECHNOLOGY has showed a −8.82% decrease.
688193 reached its all-time high on Mar 30, 2022 with the price of 72.00 CNY, and its all-time low was 22.50 CNY and was reached on Feb 6, 2024. View more price dynamics on 688193 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
688193 stock is 2.57% volatile and has beta coefficient of 1.40. Track SHANGHAI RENDU BIOTECHNOLOGY stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI RENDU BIOTECHNOLOGY there?
Yes, you can track SHANGHAI RENDU BIOTECHNOLOGY financials in yearly and quarterly reports right on TradingView.
688193 net income for the last quarter is 340.38 K CNY, while the quarter before that showed 626.90 K CNY of net income which accounts for −45.70% change. Track more SHANGHAI RENDU BIOTECHNOLOGY financial stats to get the full picture.
SHANGHAI RENDU BIOTECHNOLOGY dividend yield was 0.44% in 2023, and payout ratio reached 96.85%. The year before the numbers were 0.27% and 21.43% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 14, 2024, the company has 358.00 employees. See our rating of the largest employees — is SHANGHAI RENDU BIOTECHNOLOGY on this list?
Like other stocks, 688193 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI RENDU BIOTECHNOLOGY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI RENDU BIOTECHNOLOGY technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI RENDU BIOTECHNOLOGY stock shows the buy signal. See more of SHANGHAI RENDU BIOTECHNOLOGY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.